AU3092995A - Breast specific genes and proteins - Google Patents

Breast specific genes and proteins

Info

Publication number
AU3092995A
AU3092995A AU30929/95A AU3092995A AU3092995A AU 3092995 A AU3092995 A AU 3092995A AU 30929/95 A AU30929/95 A AU 30929/95A AU 3092995 A AU3092995 A AU 3092995A AU 3092995 A AU3092995 A AU 3092995A
Authority
AU
Australia
Prior art keywords
proteins
specific genes
breast specific
breast
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30929/95A
Inventor
Hongjun Ji
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU3092995A publication Critical patent/AU3092995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU30929/95A 1995-06-30 1995-06-30 Breast specific genes and proteins Abandoned AU3092995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/008295 WO1997002280A1 (en) 1995-06-30 1995-06-30 Breast specific genes and proteins

Publications (1)

Publication Number Publication Date
AU3092995A true AU3092995A (en) 1997-02-05

Family

ID=22249400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30929/95A Abandoned AU3092995A (en) 1995-06-30 1995-06-30 Breast specific genes and proteins

Country Status (5)

Country Link
EP (1) EP0851869A4 (en)
JP (1) JPH11509093A (en)
AU (1) AU3092995A (en)
CA (1) CA2225824A1 (en)
WO (1) WO1997002280A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6257298A (en) * 1997-02-03 1998-08-25 Human Genome Sciences, Inc. Breast cancer specific gene 1
US20020018990A1 (en) * 1997-06-20 2002-02-14 Patricia A. Billing-Medel Reagents and methods useful for detecting diseases of the breast
JP2001512668A (en) * 1997-08-06 2001-08-28 ザイモジェネティクス,インコーポレイティド Lipocalin homolog
GB9719879D0 (en) * 1997-09-19 1997-11-19 Neuropa Ltd Protein
CA2309758A1 (en) * 1997-11-18 1999-05-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US6432707B1 (en) 1997-12-24 2002-08-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6410507B1 (en) * 1997-12-24 2002-06-25 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
CA2316397A1 (en) * 1997-12-24 1999-07-08 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
US6379951B1 (en) 1997-12-24 2002-04-30 Corixa Corporation Compounds for immunotherapy of breast cancer and methods for their use
CA2316017A1 (en) * 1997-12-26 1999-07-08 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US6468758B1 (en) 1998-09-23 2002-10-22 Corixa Corporation Compositions and methods for ovarian cancer therapy and diagnosis
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
CA2392510A1 (en) 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016178A2 (en) * 1992-02-12 1993-08-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences characteristic of human gene transcription product

Also Published As

Publication number Publication date
EP0851869A1 (en) 1998-07-08
WO1997002280A1 (en) 1997-01-23
JPH11509093A (en) 1999-08-17
EP0851869A4 (en) 2002-08-14
CA2225824A1 (en) 1997-01-23

Similar Documents

Publication Publication Date Title
AU2820595A (en) Colon specific genes and proteins
AU5730896A (en) Fucosyltransferase genes and uses thereof
AU1088399A (en) F-box proteins and genes
AU4766196A (en) Anti-obesity proteins
AU4774496A (en) Anti-obesity proteins
AU4862096A (en) Anti-obesity proteins
AU4705196A (en) Anti-obesity proteins
AU4774696A (en) Anti-obesity proteins
AU4766096A (en) Anti-obesity proteins
AU6255096A (en) Pegylated modified proteins
AU6418498A (en) Human genes
AU5181296A (en) Anti-obesity proteins
GB9516059D0 (en) Novel genes and proteins
AU3092995A (en) Breast specific genes and proteins
AU5800696A (en) Rhesus ob protein and dna
GB9510830D0 (en) Proteins
AU4394396A (en) Modified peptides
AUPN631495A0 (en) Vaccine and biological vector(I)
AUPN631395A0 (en) Vaccine and biological vector(II)
AU4862396A (en) Human obesity gene
AU7520396A (en) Abl-interactor protein
AU5369396A (en) Rest protein and dna
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
AU5284296A (en) Immune-evading proteins
AU7423796A (en) Novel stress proteins